Log in or Sign up for Free to view tailored content for your specialty!
Practice Management News
Men develop IgG4-related disease more than twice as often as women
Men are more than twice as likely than women to develop IgG4-related disease, and demonstrate “striking” sex-dependent organ distribution and B-cell response, according to data published in The Lancet Rheumatology.
Disability insurance protects against financial demise
Like many sports, such as soccer and basketball, financial independence requires simultaneous offense and defense. One of the most important defensive plays a physician must make is buying disability insurance.
Log in or Sign up for Free to view tailored content for your specialty!
FDA reduces risk reporting for CAR T cells to ‘minimize the burden’ on providers
FDA has scaled back its Risk Evaluation and Mitigation Strategy reporting requirements for providers of chimeric antigen receptor T-cell therapies.
‘Ho-ho, ha-ha-ha!’ Try laughter yoga to improve well-being
To combat the myriad of stressors in life, taking a break to plug into your inner joy opens the door to increased well-being.
Protect a physician’s most valuable asset with disability insurance
Given the substantial investment to become a practicing physician, it should not be surprising that the most significant asset of most physicians is their ability to practice their profession.
Supreme Court blocks Sackler family immunity, dismantles Purdue Pharma bankruptcy plan
The U.S. Supreme Court ruled 5-4 on Thursday that members of the Sackler family cannot be protected from future lawsuits for their roles in the opioid epidemic.
Healio Minute Podcast, Rheumatology/Psoriatic Arthritis Edition: Top Headlines - Week of June 24, 2024
In this edition, extensive psoriasis and IBD history predict difficult-to-treat psoriatic arthritis, targeted therapies demonstrate low risk for serious infection and more.
JAK, IL-6 inhibition most effective targeted therapies for VEXAS syndrome
The most efficacious targeted therapies for VEXAS syndrome are Janus kinase inhibitors and interleukin-6 inhibitors, while IL-1 and TNF blockers are less effective, according to data published in the Annals of the Rheumatic Diseases.
NSAIDs, Part 2: The Dawn of the Anti-Inflammatories
In this episode, we dive into the story of aspirin and the development of ibuprofen, ending with the experiments that showed the mechanism of how aspirin actually works.
Antibody boosts platelets, shows ‘rapid and sustained efficacy’ in immune thrombocytopenia
Treatment with the novel antibody CM313 boosted platelet levels and demonstrated long-term durability among adults with immune thrombocytopenia, results from a phase 2 study showed.